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Arsenic has been associated with multiple harmful eﬀects at the cellular level. Indirectly these defects could be related to
impairment of the integrity of the immune system, in particular in lymphoid population. To characterize the eﬀect of Arsenic on
redox status on this population, copper smelter workers and arsenic unexposed donors were recruited for this study. We analyzed
urine samples and lymphocyte enriched fractions from donors to determinate arsenic levels and lymphocyte proliferation.
Moreover,we studied thepresence ofoxidativemarkersMDA,vitaminE andSODactivity indonorplasma.Here we demonstrated
that in human beings exposed to high arsenic concentrations, lymphocyte MDA and arsenic urinary levels showed a positive
correlation with SOD activity, and a negative correlation with vitamin E serum levels. Strikingly, lymphocytes from the arsenic
exposed population respond to a polyclonal stimulator, phytohemaglutinin, with higher rates of thymidine incorporation than
lymphocytes of a control population. As well, similar in vitro responses to arsenic were observed using a T cell line. Our results
suggest that chronic human exposure to arsenic induces oxidative damage in lymphocytes and could be considered more relevant
than evaluation of T cell surveillance.
1.Introduction
Transition metals are ubiquitous elements in the environ-
ment, usually present in very low quantities in soil, food,
and water. However, there are places with a combination
of high geological levels and associated economic activities
that result in chronic exposure of human populations to
toxic levels of these metals. Arsenic (As) is a transition
metal that occurs naturally in most ecosystems in northern
Chile (hydrogeological characteristic of the region), and its
presence is enhanced by human activities. Intensive copper
mining in the area has increased arsenic levels in soil
and water, thus increasing the risk to human health [1].
Nevertheless, because of mining processes, and in particular
smelting plants within the mines and around the city of
Chuquicamata, high levels of arsenic in the air are directly
aﬀecting miners [2–4]. Studies carried out on the eﬀects
of arsenic on people in work places have been considered2 Mediators of Inﬂammation
important in order to measure the occupational risk of mine
workers [5]. For instance, numerous adverse eﬀects have
been attributed to chronic arsenic exposure, including the
appearance of diﬀerent types of cancer [6], similar to studies
of copper smelter workers in the USA that have shown a
relationship between As exposure and cancer [7]. Similarly,
a retrospective study in northern Chile involving people
in areas with high exposure to arsenic showed increased
incidence of lung, skin, and bladder cancer [8].
At the molecular level, physiopathological eﬀects related
to arsenic toxicity appear to involve diﬀerent mechanisms
and intracellular targets. Oxidative stress is among the most
documented mechanisms of As toxicity and carcinogenicity.
Oxidative stress is the result of an imbalance between
radicaloxygenspecies(ROS)productionandtheantioxidant
defense system. Antioxidant response is one of the most
eﬃcient cellular defense mechanisms. Numerous enzymatic
and nonenzymatic factors participate in cell protection
by clearing and scavenging ROS. Superoxide dismutase
(SOD) and vitamin E are among the main enzymatic
and nonenzymatic mechanisms, respectively, involved in
antioxidant response to As. The major active compounds
of oxidative stress and oxidative signalling induced by As
are ROS, which are able to damage molecules like DNA,
proteins, and membrane lipids, generating the activation
of signalling pathways to carcinogenesis. In general, the
most important targets for arsenic-containing compounds
appear to be mitochondrial proteins with a deﬂection of
electrons from the respiratory chain to generate ROS. As
well, ROS might be produced by cytosolic enzymes with
peroxidase activity or during the oxidation of As(III) to As(V)
(reviewed in [9]). ROS production by As may result in
an attack, not only against antioxidant defenses and DNA,
but also against membrane phospholipids, which are very
sensitive to oxidation, producing peroxyl radicals and then
malondialdehyde (MDA). In this regard, the application
of radical scavengers has revealed the involvement of As-
induced ROS in the induction of lipid peroxidation, as well
as in DNA damage [10].
The aim of this work was to determine whether arsenic-
driven oxidative activity shows a correlation with potential
changes in lymphocytesobtained from coppersmelter work-
ers. We determined in vitro that lymphocytes from a highly
exposed population showed higher thymidine incorporation
compared to the control population. Moreover, a positive
correlation between arsenic urinary levels and lymphocyte
MDAlevelsandSODactivity,aswell asanegativecorrelation
with vitamin E serum levels, was observed. Similarly, SOD
showed increased activity in highly exposed individuals
and a positive correlation with As in urine. Our results
indicate that chronic As exposure induces oxidative damage
in lymphocytes.
2.Materialsand Methods
2.1.Ethics. The presentstudy was carried outinAntofagasta,
a northern region of Chile, where miners are environ-
mentally exposed to high levels of arsenic. Protocols were
approved by the Ethics Committee of the University of
Santiago, Chile. All subjects signed an informed consent
form.
2.1.1. Volunteers. From 160 smelter workers (section con-
verters), a group of 40 were recruited for this study, workers
met the following requirements: nonsmokers, no cardio-
vascular problems, and no severe problems of overweight,
but with sedentary habits (none of them practiced sports
regularly). None of them showed problems of alcoholism
or symptoms of chronic illness such as hypertension or
diabetes. Volunteers had a mean age of 43 ± 6y e a r s( r a n g e
29–57), height 171.3 ± 5.5cm (range 1.60–1.81), weight
74.9 ± 6.2Kg, and body mass index of 25.6 ± 1.9( r a n g e
21.5–29). As a control, thirty-two men with a mean age
of 40 ± 7 years unexposed to arsenic smelt were recruited
from Antofagasta. The control subjects have been exposed
to minimal concentrations of arsenic in drinking water,
with undetectableAsurinary levels.Concerning the samples,
The ﬁrst morning urine sample and other urine samples
were collected in polypropylene specimen containers and
stored at −20◦C before use. Blood samples were taken using
sealed ethylenediaminetetraacetic acid (EDTA) Vacutainer
Pb-free test tubes. Samples were stored at 4◦C for less
than8huntilcellseparation.Lymphocyte-enrichedfractions
were obtained from blood samples using Ficoll-Histopaque
gradient sedimentation according to the manufacturer’s
protocol (Sigma Chem. Co., St. Louis, MO).
2.2. Proliferation Assay. To asses lymphocyte proliferation
a[ 3H]-TdR incorporation assay was carried out under
standard conditions, as described previously [11]. Brieﬂy,
1 × 105 cells were seeded in 96 well plates and exposed
simultaneously to sodium arsenite (10−6 M) and 0.5μg/ml
PHA (Sigma Chem. Co., St. Louis, MO). Cells were incu-
bated for 48h and then pulsed with 2μCi/well of [3H]-TdR
(Amersham Life Science).After 24h cells were recovered and
lysed with trichloroacetic acid 10%. The incorporation of
[3H]-TdRwasmeasured byliquidscintillation(Beckman,LS
6500). Background proliferation was determined using non-
stimulated cellsand subtracted from totalcounts,Jurkat cells
2.3. Determination of Arsenic Levels in Urine. Urine samples
were thawed at room temperature, diluted 10-fold, and
centrifugedat3000 ×gat4 ◦Cfor30minutes.The precipitate
was discarded, and the supernatant was passed through a
0.45μm ﬁlter (Waters, GHP Arcordisc Minispike). Then
supernatants were diluted to 10ml, and quantization of
total content of arsenic was performed using an atomic
absorption spectrophotometer, equipped with a standard
Varian air-acetylene ﬂame atomizer, as described previously
in [12, 13]. Detection was done using a system coupling ﬂow
injection analysiswith hydride generationatomicabsorption
spectrometry (FIA/HGAAS),as described previously in [14].
2.4. Determination of Oxidative Markers. MDA formation
was used to quantify lipid peroxidation in tissues and
was measured as thiobarbituric acid-reactive material. FiveMediators of Inﬂammation 3
million cells were homogenized in 1.15% KCl buﬀer.
Homogenates were then added to a reaction mixture
consisting of 1.5ml of 0.8% thiobarbituric acid, 2ml of
8.1% (vol/vol) SDS, 1.5ml of 20% (vol/vol) acetic acid
(pH 3.5), and 6ml of distilled H2O and heated at 90◦C
for 45 minutes. After cooling at room temperature, the
samples were cleared by centrifugation at 10,000rpm for
10 minutes, and absorbance was measured at 532nm by
using 1,1,3,3-tetramethoxypropane as an external standard.
The level of lipid peroxides was expressed as nanomol MDA
per milligram of protein. Vitamin E was determined using
HPLC as described previously in [15]. Standard curves
were prepared by chromatographing known amounts of α-
tocopherol (Sigma Chemical Co). All solvents were HPLC
grade and ﬁltered through Millipore 0.22μm membranes
prior to use. These were washed with 5ml each of diethyl
ether and methanol before use. Vitamin E was eluted in
silica gel columns (Bond Elut SI #601313 Analytichem
International) and detection was performed by HPLC with a
diode array detector. SOD activity was determined using the
method of Misra and Fridovich [16] based on the inhibition
of epinephrine autoxidation to adrenochrome.
2.5. Statistical Analysis. The Pearson R value was determined
to test statistical correlations between MDA, Vitamin E,
SOD activity, and arsenic concentration in urine. The
diﬀerence in urine As content between the highly exposed
group and the low-exposure group was analyzed using
the U-Mann Whitney test. The diﬀerence in 3H-thymidine
incorporation in lymphocytes between the control and As-
exposed workers was analyzed using an unpaired t-test with
Welch’s correction. The multiple lineal correlation analysis
betweentheurineAsconcentrationwastheoutcomevariable
and sample T cell proliferation; plasmatic MDA and vitamin
E concentrations were the causal variables. The statistical
analysis was performed using Graphpad prism 5.0 software.
All the statistical analyses were performed with a signiﬁcance
value of P ≤ .05.
3.Results
3.1. Arsenic Eﬀects in Lymphocytes of the Exposed Population.
Exposure to arsenic has been correlated with an increased
prevalenceto developseveraldiseases in human populations,
including genotoxic damage and cancer. The main goal
of this study was to evaluate the eﬀects of arsenic on
lymphocytes because damage to these cells could shed light
on diseases developed in highly exposed populations. First,
we evaluated [3H]-TdR incorporation in PHA-stimulated
lymphocytesisolated from a highly exposed Asgroup,aswell
as a control group of peoplefrom the same area. Asshown in
Figure 1(a), lymphocyte proliferation was observed in both
groups of people studied. However, lymphocytes from the
As-exposed population showed a higher rate of [3H]-TdR
incorporationcomparedtothoseofthecontrolgroup(3.32±
0.09 and 2.98 ± 0.47, resp., P = .014). Interestingly, there
was a positive correlation (P = .002) between [3H]-TdR
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Figure 1: Comparative eﬀect of arsenic exposure on the prolif-
eration of lymphocytes isolated from low- and high-As-exposure
human populations. Correlation of lymphocyte proliferation and
urinary excretion of As from highly As-exposed population. (a)
Proliferation was assessed by comparison of 3H-Thymidine incor-
poration ([3H]-TdR, cpm) in lymphocytes isolated from the low-
As-exposure group (control group, n = 31) and from the high-As-
exposure group (n = 50). Statistically signiﬁcant diﬀerences were
found between the two groups (U-Mann-Whitney test P = .0138).
(b) Relationship between 3H-Thymidine incorporation and arsenic
concentration in urine (ppm) of the highly exposed population
(n = 50). Association between the two variables was determined
by R-Pearson (P = .002).
incorporation and arsenic salts present in urine collected
over 24h (Figure 1(b)).
We also evaluated the MDA, vitamin E, and plasmatic
SOD activity on control and exposed populationsto conﬁrm
oxidative stress and damage in lymphoid cells. As shown
in Figure 2(a), MDA distribution in the two populations
was diﬀerent, being higher in the plasma of the highly
exposed population compared to low-exposure population
(6.231±1.01and 4.125±1.31μM, resp., P<. 0001).Analysis
showed a signiﬁcant andpositive correlationbetweenplasma
MDA levels and arsenic in urine (P<. 0001) (Figure 2(b)).
If oxidative stress is related to an increase in oxidation
of metabolites, response to arsenic injury might also be4 Mediators of Inﬂammation
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Figure 2: Comparative eﬀect of arsenic exposure on lipid per-
oxidation in blood samples from low- and high-exposure human
populations. (a) Comparison of MDA distribution proﬁle in blood
samples isolated from low-As-exposure (control, n = 31) and
high-As-exposure (n = 50) human populations.Lipid peroxidation
was assessed by plasma MDA concentration. The statistical analysis
indicates signiﬁcant diﬀerences between the two groups (test
U-Mann-Whitney P<. 0001). (b) Correlation between MDA
concentration and urinary excretion of As in the high As-exposure
population (n = 50). The associations between the two variables
were determined by R-Pearson (P< . 0001).
related to changes in plasmatic concentration of natural
antioxidants. In support of this idea, we found that vitamin
E plasma levels were lower in the highly exposed population
than in the low-exposure population (9.765 ± 3.547 and
16.44 ± 4.332, resp., P<. 0001) (Figure 3(a)). Moreover,
we found an inverse correlation between vitamin E and
urine concentration of arsenic (P<. 0018) (Figure 3(b)).
SOD activity measured from plasma samples in the control
group was signiﬁcantly higher than that in the high-As-
exposure population (28.82±12.39and 25.29±9.186,resp.)
(Figure 4(a)), and this enzymatic activity correlates well with
As concentration in urine from this population (P<. 0001)
(Figure 4(b)). Altogether, these results indicate that arsenic
induces a signiﬁcant increase of damage driven by free
radicals in highly exposed people. To conﬁrm a correlation
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Figure 3: Comparative levels of vitamin E in plasma samples
from low- and high-exposure human populations and correlation
between plasma vitamin E concentration and urinary excretion of
AsfromhighlyAs-exposed population.(a)VitaminEconcentration
proﬁle in the plasma of the low-As-exposure group (n = 31)
and the high-As-exposure group (n = 50). The statistical analysis
indicates signiﬁcant diﬀerences between the two groups (U-Mann-
Whitney test P<. 0001). (b) Relationship between plasma vitamin
E concentration (μM) and As concentration in urine (ppm) from
the highly exposed population. The relationship between the two
variables was determined by R-Pearson (P<. 0018).
between arsenic and the changes described in redox status,
a multiple lineal correlation analysis was carried out. This
correlation indicates that urine As concentration does not
correlate with the sample T cell proliferation (P = .096) but
doescorrelatewithplasmaticMDAconcentration(P = .004)
and vitamin E concentration (P = .015). Additionally the
standardized correlationcoeﬃcientsindicatethatanincrease
in urine As concentration correlates with an increase in
plasma MDA concentration and decreased plasma vitamin E
(standardizedcoeﬃcients0.374and −0.294,resp.)indicating
an increase in oxidative stress.
3.2. Arsenic Eﬀects on the In Vitro Proliferation of Human
Cells. Once the lymphocyte response and oxidative status
of the highly exposed population had been characterized,Mediators of Inﬂammation 5
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Figure 4: Comparative levels of SOD activity in plasma samples
from low- and high-exposure human populations and correlation
between SOD activity and urinary excretion of As from highly As-
exposed population. (a) SOD activity in the plasma samples of
the low-As-exposure group (n = 31) and high-As-exposure group
(n = 50). Data are graphed as mean standard error (P<. 0001). (b)
Relationship between plasma SOD activity and As concentration
in urine from highly exposed population (P<. 0001). Statistical
diﬀerences of SOD activity between the groups were established
according to U-Mann-Whitney test.
we evaluated the eﬀect of arsenic on T-lymphoma Jurkat
cells. First, As (III) induced a reduction of thymidine
incorporation during basal proliferation of human ﬁbrob-
last cultures in a concentration-dependent form (data not
shown). In contrast, a dual eﬀect was observed in PHA-
induced proliferation of Jurkat cells, that is, doses of 0.2 to
2ppm of arsenic diminished [3H]-TdR incorporation, but
lower doses of As (lower than 0.2ppm) induced an increase
(Figure 5(a)). As shown in Figure 5(b), the increase in [3H]-
TdR incorporation did correlate to the total cell number in
doses ranging from 0.05 to 0.2ppm. Instead, a signiﬁcant
dose-dependent decrease of cell growth was observed until
cell proliferation is completely arrested.
In order to evaluate oxidative stress-related response,
lipid damage in response to arsenic treatment of Jurkat cells
was studied by determining MDA levels, a marker of lipid
peroxidation.Resultsshowedthatarsenicinducesanincrease
in MDA in a dose-dependent manner, with a maximum
increase observed at 0.2ppm of arsenic (Figure 5(c)). Higher
concentrations of the metal induced a decrease in MDA
levels in Jurkat cells. Our results are in agreement with
previous reports and support the hypothesis that low levels
of arsenic induce mechanisms of DNA repair in cells because
of oxidative cell damage.
4.Discussion
In this work we demonstrated that chronic arsenic exposure
correlates with an increase in oxidative damage in lym-
phocytes and a downregulation of antioxidant mechanisms.
Meanwhile, the mechanism of action of As in lymphocytes
is not completely understood, the current consensus is that
arsenic causes oxidative stress [17]. In this way, induction
of several ROS best characterizes the eﬀect of As exposure
that causes cell damage [9]. Alteration in the antioxidant
cell system has been reported in many pathologies involving
metal-induced oxidative stress [18].
Here, we have demonstrated that humans chronically
exposed to As also present changes in peripheral blood lym-
phocytes. Probably, the lymphocytes are trying to develop
a response against the oxidative challenge, thus increasing
antioxidant defences. In this respect, the literature is con-
tradictory, showing that lymphocytes treated in vitro with
arsenic exhibit a lower level of activity of some antioxidant
enzymes, such as catalase, glutathione peroxidase, and SOD
[19]. However, this study was conducted in vitro and with
acute exposure. On the other hand, another work reported
thatAs exposure inducedsigniﬁcantly higher SODactivity in
vitro[20].Astudyconductedin InnerMongolia,China,with
humans exposed to highly contaminated drinking water,
did not show signiﬁcant diﬀerences in blood SOD activity
[21]. However, the authors of this study compared the
highly exposed population to a group with low exposure,
the latter still having twice the As level as accepted level
for drinking water by the World Health Organization. In
light of our results, however, in humans chronically exposed
to As-contaminated air SOD activity is induced in a direct
relationship to As excreted, and probably to the levels of
As in plasma. As well, the response to As-induced damage
can include modiﬁcation of cellular antioxidant uptake
or alteration in the activity or its oxidation. The use of
antioxidants like vitamin E has been described as an eﬃcient
strategy to protect cells from As-induced oxidative damage
[22]. However, until now no examination of the levels of
vitamin E in blood in an exposed population has been
described. We found a signiﬁcant decrease in vitamin E,
which is directly related to the excreted As levels.
Strikingly, there is controversial evidence about the eﬀect
of arsenic on lymphocyte proliferation, in vitro challenge
resultsininhibitinglymphocyteproliferationassociatedwith
decreased thymidine incorporation. In vitro studies indicate
that arsenic-delayed proliferation of T-lymphocytes and
modiﬁed DNA synthesis occur in a biphasic dose-dependent
manner [23, 24], high doses of As inhibit PHA-induced6 Mediators of Inﬂammation
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Figure 5: Eﬀect of sodium arsenite on Jurkat cells. (a) Inhibition of proliferation of PHA-stimulated Jurkat cells by sodium arsenite. Cells
(2 × 105 cells/well) were incubated as indicated before, and proliferation was assessed by [3H]-TdR incorporation. Results are expressed in
counts per minute (cpm) in the absence and presence of diﬀerent sodium arsenite concentrations. (b) Evaluation of proliferation of cells
(2 × 10
5 cells/well) stimulated with 5μg/ml PHA for 48h. Results are expressed as the number of cells obtained in the presence of diﬀerent
sodium arsenite concentrations in the culture media. (c) Lipid peroxidation in Jurkat cells induced by arsenic. Cells (2×10
5 cells/well) were
incubated with sodium arsenite for 48h and the level of lipid peroxides was measured in the homogenates as MDA concentration.
T cell proliferation [23, 25, 26], while lower arsenic doses
used in vitro increase lymphocyte proliferation induced by
PHA, in agreement with our results in vitro [24, 27]. On
the other hand, while we determined that lymphocytes of
exposed workers show increased thymidine incorporation,
the literature reports decreased lymphocyte proliferation
in a murine model [28] and decreases or no changes in
lymphocytes of people exposed to arsenic in drinking water
in Mexico. A report shows that adults chronically exposed
to high levels of As had lymphocytes with a lower average
generation time compared to that of individuals with less
exposure to the metal. Unfortunately, the number of cases
analysed was low and did not permit comparison with
conﬁdence[29].OthercasesofadultsinMexicodidnotshow
changesinthereplicativeindexoflymphocyteobtainedfrom
individuals with chronic exposure to As via drinking water
[30]. A more recent study suggests that lymphocytes from
childrenexposed to As show reduced cell mitogenic response
to PHA [31]. All of these observations are in disagreement
with our results. Unfortunately, we do not have explanations
for these diﬀerences, except that the doses present in the
workers in our study could have been lower than those
observed in people exposed to arsenic from water or could
be related to regionally speciﬁc diﬀerences and other metals
present in the air, mines, orin the water in Mexico. However,
it has been repeatedly suggested and demonstrated that the
exposure of cells to low levels of ROS induces division
and proliferation (for review see [32]). It has been widely
documented that the use of antioxidant or ROS scavengers,
as discussed above, protects against As-induced damage. In
this respect, we can speculate that the induction of cell
proliferation can be found at levels of As concentration at
which the toxicity is mainly due to ROS generation.
A retrospective study in the same geographic area as our
study recently described an increased prevalence of cancer
compared to other parts of Chile [8]. Similarly, other studiesMediators of Inﬂammation 7
reported that chronic inhalation of arsenic is related to
leukaemia and lung cancer and urinary excretion of arsenic
metabolites [33–35]. In the USA, arsenic in drinking water
has been correlated with several diseases, such as cancer,
cardiovascular disease, and diabetes [36–41]. The role of
arsenic in cancer induction has been not clearly established,
butitissupportedbytheideaofgeneratinggenotoxicity.Our
resultssupporttheideathattheprevalenceofcancercouldbe
related bothto changes in oxidativestress, which can damage
the genome, and to altered lymphocyte activity or response.
In this way, there is substantial evidence supporting the
latter idea, besides the changes described in the proliferative
response of lymphocytes. For instance, in vitro studies
indicate that As inhibits IL-2 and IL-4 secretion and CD25
expression [23, 25, 26]. As well, it has been reported in India
and in the other countries, where human populations have
been exposed to arsenic in drinking water, that peripheral
lymphocytesshowanincreasedfrequencyofsisterchromatid
exchanges [42–44]. Moreover, Yu and coworkers showed
that PBMC from patients with arsenic-induced Bowen’s
disease had a decreased percentage of T cells, particularly the
T helper subpopulation [45]. Other important and recent
evidence implies that lower in vitro concentrations of arsenic
increase the number and function of T regulatory lympho-
cytes [46]. Altogether, the damage induced in proliferative
c e l l s ,a sw e l la st h en o x i o u se ﬀects on lymphocyte functions,
that is, induction of anti-inﬂammatory and T regulatory
lymphocytes at low concentrations, supports a diﬀerent role
of arsenic, not only as a possible inductor of cancer but
also linked to impaired lymphocyte function. However, we
cannot exclude other transition metals that are also capable
of causing oxidative degradation of lymphocytes.
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